Quinine Sulphate  BP Art.no. 014 (Accord) - API

Quinine Sulphate BP Art.no. 014 (Accord) - API

Quinine Sulphate BP is a high-quality active pharmaceutical ingredient (API) manufactured in accordance with British Pharmacopoeia standards. It is widely used in pharmaceutical formulations for its antimalarial and antipyretic properties, ensuring consistent performance, purity, and compliance for regulated markets.

Packaging
-
  • Category

    PharmaceuticalsAPI
  • Sectors

    Pharma

What is Quinine Sulphate BP Art.no. 014 (Accord) - API

Quinine Sulphate BP is a well-established alkaloid derived from the bark of the cinchona tree. Produced to meet stringent British Pharmacopoeia (BP) specifications, this API delivers dependable purity, stability, and batch-to-batch consistency required for pharmaceutical manufacturing. It is commonly utilised in formulations aimed at treating malaria and managing nocturnal leg cramps, under appropriate medical guidance.

The product undergoes rigorous quality control processes, ensuring compliance with global regulatory expectations and suitability for inclusion in both solid and liquid dosage forms. Its reliable solubility profile and proven therapeutic efficacy make it a preferred choice in the development of antimalarial medications. With a strong legacy in pharmaceutical use, Quinine Sulphate BP continues to be a trusted ingredient in critical healthcare applications, supporting effective treatment outcomes in diverse markets.

Quinine Sulphate  BP Art.no. 014 (Accord) - API
  • Active Ingredient
  • Healthcare
  • BP Standard
  • Pharmaceutical API
  • GMP compliant
  • High Purity
  • Antimalarial
  • Regulated Markets

Applications & Functionalities

Quinine Sulphate BP is primarily used as an essential API in the formulation of antimalarial medications, where it plays a key role in inhibiting the growth of Plasmodium parasites in the bloodstream. Its pharmacological properties also make it suitable for use in treatments addressing muscle cramps, particularly nocturnal leg cramps, when prescribed appropriately. The product demonstrates reliable solubility and compatibility with various excipients, allowing for flexibility in formulation design across tablets, capsules, and oral liquid preparations. Its adherence to BP standards ensures formulators can achieve consistent quality and regulatory compliance. Additionally, its long-standing clinical use supports its inclusion in legacy and modern therapeutic formulations alike.

Quinine Sulphate BP is primarily used as an essential API in the formulation of antimalarial medications, where it plays a key role in inhibiting the growth of Plasmodium parasites in the bloodstream. Its pharmacological properties also make it suitable for use in treatments addressing muscle cramps, particularly nocturnal leg cramps, when prescribed appropriately. The product demonstrates reliable solubility and compatibility with various excipients, allowing for flexibility in formulation design across tablets, capsules, and oral liquid preparations. Its adherence to BP standards ensures formulators can achieve consistent quality and regulatory compliance. Additionally, its long-standing clinical use supports its inclusion in legacy and modern therapeutic formulations alike.

Common applications include:

  • Antimalarial formulations
  • Pharmaceutical tablets
  • Capsules
  • Oral solutions
  • Muscle cramp treatments.

Related Ingredients

Need specialist support? Let's talk

Speak to one of our specialist team and get the expert support you need.

Get in Touch

Cookies

We use cookies to ensure you get the best experience on our website. Learn more about cookies